Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $139.69 Analyst target: $170.50 Upside: 22.06%
Veradermics, Incorporated is a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company is headquartered in New Haven, Connecticut.
See the full interactive analysis & chart →Informational only — not investment advice.